Companies that obtain an ADGM licence will enjoy certain benefits, including a streamlined transition process
The Phase I clinical trial, which evaluated the safety, tolerance, and preliminary immunogenicity of the COVID-19 vaccine, commenced in April.
The company recently published pre-clinical results regarding CoronaVac, noting that the vaccine candidate was safe and provided protection to rhesus monkeys through an animal challenge study.
After preliminary observation of the safety profile of CoronaVac in the Phase I study, Sinovac began conducting Phase II trial in May that involved more than 1,000 volunteers. The Phase II clinical trial evaluated the immunogenicity and safety of the vaccine in a larger population in order to define dosage, regimen, and immunization schedule.
Sinovac has secured $15 million in funding to accelerate its Covid-19 vaccine development and is constructing a commercial vaccine production plant that is expected to produce up to 100 million doses annually.
According to a report by Sky News, when Luo Baishan, a researcher at Sinovac, was asked by their reporter whether he thought the vaccine would be successful, he said, "Yes, yes. It must be successful, 99 per cent (sure)."
Companies that obtain an ADGM licence will enjoy certain benefits, including a streamlined transition process
If you're planning a trip to Dubai, be sure to visit Renty for a first-class driving experience
The actor attended the event in the UAE along with his family
Tremors were felt in the Greek capital of Athens and as far away as the southern island of Crete
The Buyback Programme is a huge step in creating solutions for nature
Dozens of other products that contain benikoji — including miso paste, crackers and a vinegar dressing — have been withdrawn from the market
The passengers were on a trip to an Easter weekend church gathering